Daniel Brims
Stock Analyst at Lake Street
(0.04)
# 4,346
Out of 4,357 analysts
19
Total ratings
18%
Success rate
-37.8%
Average return
Main Sectors:
Stocks Rated by Daniel Brims
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics | Maintained: Buy | $45 | $5.35 | +741.12% | 2 | Jun 1, 2026 | |
| VKTX Viking Therapeutics | Initiated Coverage: Buy | $89 | $31.27 | +184.62% | 1 | May 28, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $9 | $0.8957 | +904.80% | 1 | May 18, 2026 | |
| PIII P3 Health Partners | Rated: Buy | $962 | $12.91 | +7,351.59% | 1 | May 15, 2026 | |
| LITS Lite Strategy | Reiterated: Buy | $7 | $0.958 | n/a | 7 | Sep 2, 2015 | |
| IMNN Imunon | Maintained: Buy | $7 | $2.15 | n/a | 6 | Aug 10, 2015 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Buy | n/a | $7.36 | n/a | 1 | Dec 30, 2014 |
Aligos Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $45
Current: $5.35
Upside: +741.12%
Viking Therapeutics
May 28, 2026
Initiated Coverage: Buy
Price Target: $89
Current: $31.27
Upside: +184.62%
Rani Therapeutics Holdings
May 18, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8957
Upside: +904.80%
P3 Health Partners
May 15, 2026
Rated: Buy
Price Target: $962
Current: $12.91
Upside: +7,351.59%
Lite Strategy
Sep 2, 2015
Reiterated: Buy
Price Target: $7
Current: $0.958
Upside: n/a
Imunon
Aug 10, 2015
Maintained: Buy
Price Target: $7
Current: $2.15
Upside: n/a
Bausch Health Companies Inc.
Dec 30, 2014
Maintained: Buy
Price Target: n/a
Current: $7.36
Upside: n/a